
Keywords: توسعه بازدارنده; OAS; O-acetyl serine; OPS; O-phosphoserine; PLP; pyridoxal-5-phosphate,APS, adenosine 5â²phosphosulfate, SAR, structure-activity relationships.; Tuberculosis; Cysteine biosynthesis; Pyridoxal-dependent enzymes; Cysteine synthases; Inhibitor development